DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,698,000 | +48.4% | 115,896 | +8.3% | 0.00% | 0.0% |
| Q4 2018 | $1,144,000 | -59.5% | 107,059 | -42.1% | 0.00% | 0.0% |
| Q3 2018 | $2,822,000 | +171.1% | 184,958 | +117.6% | 0.00% | +100.0% |
| Q2 2018 | $1,041,000 | +628.0% | 85,004 | +218.7% | 0.00% | – |
| Q1 2016 | $143,000 | -45.4% | 26,668 | +20.8% | 0.00% | – |
| Q4 2015 | $262,000 | +44.8% | 22,080 | 0.0% | 0.00% | – |
| Q3 2015 | $181,000 | -41.2% | 22,080 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $308,000 | +156.7% | 22,080 | +341.1% | 0.00% | – |
| Q1 2015 | $120,000 | +46.3% | 5,006 | -90.7% | 0.00% | – |
| Q4 2014 | $82,000 | +28.1% | 53,839 | +975.5% | 0.00% | – |
| Q3 2014 | $64,000 | -43.4% | 5,006 | 0.0% | 0.00% | – |
| Q2 2014 | $113,000 | +11.9% | 5,006 | +40.6% | 0.00% | – |
| Q1 2014 | $101,000 | – | 3,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |